These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4862960)

  • 21. The value of serum diphenylhydantoin (phenytoin) levels in the management of epilepsy.
    Reynolds EH
    Proc R Soc Med; 1975 Feb; 68(2):102-4. PubMed ID: 1166035
    [No Abstract]   [Full Text] [Related]  

  • 22. [Analysis of the range of action of a medication].
    Ostaptzeff M; Lavoine JR; Ostaptzeff G
    Ann Med Psychol (Paris); 1974 Feb; 1(2):255-64. PubMed ID: 4603332
    [No Abstract]   [Full Text] [Related]  

  • 23. Role of combination of valproic acid with diphenylhydantoin and carbamazepine in the management of intractable seizures.
    Ashok PP; Maheshwari MC
    J Assoc Physicians India; 1984 Jul; 32(7):565-7. PubMed ID: 6438054
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical pharmacology of drug interactions.
    Raisfeld IH
    Annu Rev Med; 1973; 24():385-418. PubMed ID: 4575864
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of personality and behavior disorders in childhood epilepsy with Neuleptil].
    Nagayama T; Takeshita K; Kurakawa T
    No To Shinkei; 1967 Sep; 19(9):935-40. PubMed ID: 4866508
    [No Abstract]   [Full Text] [Related]  

  • 26. [Study of 1317-A.N., Leptryl. Possibilities in psychiatric treatment with a new phenothiazine: perimetazine or 1317 A.N].
    Rainaut J
    Mars Med; 1970; 107(4):353-61. PubMed ID: 4912083
    [No Abstract]   [Full Text] [Related]  

  • 27. Diphenylhydantoin dosage.
    Eadie MJ; Tyrer JH; Hooper WD
    Proc Aust Assoc Neurol; 1973; 10(0):53-9. PubMed ID: 4792162
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical evaluation of the TPN 12 (Sandoz) preparation in the treatment of mental disorders].
    Bukowczyk A; Korta B; Michalska M; Spisla B; Trzeciakowa O; Bryś J
    Psychiatr Pol; 1971; 5(5):571-5. PubMed ID: 4400423
    [No Abstract]   [Full Text] [Related]  

  • 29. Diphenylhydantoin. Its usefulness in clinical disorders of a non-epileptic nature. Discussion on safety.
    Int J Neuropsychiatry; 1967 Dec; 3():Suppl 2:64-6. PubMed ID: 4870959
    [No Abstract]   [Full Text] [Related]  

  • 30. [Determination of serum diphenylhydantoin during antiepileptic therapy].
    Müller-Stüler M
    Nervenarzt; 1976 Apr; 47(4):244-7. PubMed ID: 1272481
    [No Abstract]   [Full Text] [Related]  

  • 31. Delayed and insidious onset of diphenylhydantoin toxicity.
    Herberg KP
    South Med J; 1975 Jan; 68(1):70-5. PubMed ID: 1154062
    [No Abstract]   [Full Text] [Related]  

  • 32. A comparison of mesoridazine and chlorpromazine in chronic psychiatric patients.
    Douglas KW; Hindley JP
    J Clin Pharmacol J New Drugs; 1969; 9(3):176-82. PubMed ID: 4892453
    [No Abstract]   [Full Text] [Related]  

  • 33. Serum concentrations of diphenylhydantoin (phenytoin) and phenobarbital and their relation to therapeutic and toxic effects.
    Buchthal F; Svensmark O
    Psychiatr Neurol Neurochir; 1971; 74(2):117-36. PubMed ID: 5004709
    [No Abstract]   [Full Text] [Related]  

  • 34. Piperacetazine in ambulatory chronic schizophrenic patients.
    Rada RT; Donlon PT
    Curr Ther Res Clin Exp; 1974 Feb; 16(2):124-9. PubMed ID: 4156665
    [No Abstract]   [Full Text] [Related]  

  • 35. Combined therapy in chronic schizophrenics stabilized on phenothiazine tranquilizers and given BL-KR140 or imipramine or placebo concurrently.
    Claghorn JL; Schoolar JC; Ryan JW; Kinross-Wright J
    Curr Ther Res Clin Exp; 1967 Nov; 9(11):576-8. PubMed ID: 4965507
    [No Abstract]   [Full Text] [Related]  

  • 36. Diphenylhydantoin effectiveness in the treatment of chronic schizophrenics. A double-blind controlled study with a placebo.
    Simopoulos AM; Pinto A; Uhlenhuth EH; McGee JJ; DeRosa ER
    Arch Gen Psychiatry; 1974 Jan; 30(1):106-11. PubMed ID: 4587066
    [No Abstract]   [Full Text] [Related]  

  • 37. [Anti epileptic therapy with diphenylhydantoin with serum controls in childhood. Clinical experiences].
    Nolte R; Brügmann G; Besch W
    Bibl Psychiatr; 1975; (151):43-8. PubMed ID: 1156347
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical experience with conductase].
    De Gúzmán Rodríguez
    Arch Neurobiol (Madr); 1971; 34(1):71-84. PubMed ID: 4940150
    [No Abstract]   [Full Text] [Related]  

  • 39. [Note on the use of dihydrogenated derivatives of ergotoxin (Hydergine) and their association with psychopharmacology in the treatment of aged neuropsychiatric patients].
    Bertolotti P; Spaggiari G
    Riv Sper Freniatr Med Leg Alien Ment; 1966 Oct; 90(5):1243-58. PubMed ID: 4968439
    [No Abstract]   [Full Text] [Related]  

  • 40. [Monitoring of plasma diphenylhydantoin levels in epileptic patients].
    Lezama-Dávila CM; Olmos-García de Alba G; López-Anaya A; Valarezo-Crespo F
    Bol Med Hosp Infant Mex; 1983 May; 40(5):256-61. PubMed ID: 6871012
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.